Literature DB >> 17439518

Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy.

J M Péron1, C Bureau, H Poirson, J M Mansuy, L Alric, J Selves, E Dupuis, J Izopet, J P Vinel.   

Abstract

Fulminant hepatitis E has not been well characterized in industrialized countries. The aim of this study was to prospectively describe patients with acute hepatitis E presenting as fulminant hepatic failure, i.e. with encephalopathy and prothrombin index <50%. Between February 1997 and April 2005, seven patients with encephalopathy were diagnosed with acute hepatitis E using viral RNA detection. These patients were compared with 33 patients diagnosed with a mild form (absence of encephalopathy) of acute hepatitis E during the same time period. Patients were 65 +/- 11 years old. Five were active drinkers and six had chronic liver disease. All hepatitis E virus sequences evaluated (5/7) were of genotype 3. All patients but two died (71%). Four patients had no travel history. When compared with patients with a mild form of acute hepatitis E, active alcohol abuse and chronic liver disease were more frequent in patients with the severe form. Duration of hospitalization was longer. Aspartate transferase and bilirubin levels were significantly higher. Prothrombin index and accelerin levels were lower and death was more frequent. Acute nontravel-associated hepatitis E can appear as fulminant hepatitis with encephalopathy and coagulation disorders. Prognosis is severe and this may be due to the age at which it occurs and frequent underlying chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17439518     DOI: 10.1111/j.1365-2893.2007.00858.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  69 in total

1.  Hepatitis: hepatitis E and decompensated chronic liver disease.

Authors:  Harry R Dalton
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-06-26       Impact factor: 46.802

Review 2.  Acute and Persistent Hepatitis E Virus Genotype 3 and 4 Infection: Clinical Features, Pathogenesis, and Treatment.

Authors:  Nassim Kamar; Sven Pischke
Journal:  Cold Spring Harb Perspect Med       Date:  2019-07-01       Impact factor: 6.915

3.  Hepatitis E in Israel: A nation-wide retrospective study.

Authors:  Ortal Erez-Granat; Tamar Lachish; Nili Daudi; Daniel Shouval; Eli Schwartz
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

4.  Fatal autochthonous fulminant hepatitis E early after allogeneic stem cell transplantation.

Authors:  M Carré; A Thiebaut-Bertrand; S Larrat; V Leroy; P Pouzol; N Sturm; S Lhomme; J-Y Cahn; F Garban; P Morand
Journal:  Bone Marrow Transplant       Date:  2017-01-09       Impact factor: 5.483

5.  Knowledge Is Safety: The Time Is Ripe for Hepatitis E Virus Blood Donor Screening.

Authors:  Tanja Vollmer; Cornelius Knabbe; Jens Dreier
Journal:  Transfus Med Hemother       Date:  2016-11-02       Impact factor: 3.747

6.  Hepatitis E Virus Infection and Cirrhosis of the Liver.

Authors:  Jean-Marie Péron
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-09

7.  The Enigma of Hepatitis E Virus.

Authors:  Liza Bronner Murrison; Kenneth E Sherman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-08

Review 8.  Zoonotic hepatitis E: animal reservoirs and emerging risks.

Authors:  Nicole Pavio; Xiang-Jin Meng; Christophe Renou
Journal:  Vet Res       Date:  2010-04-02       Impact factor: 3.683

Review 9.  An update on the hepatitis E virus.

Authors:  Seth N Sclair; Eugene R Schiff
Journal:  Curr Gastroenterol Rep       Date:  2013-02

10.  Natural course of fulminant hepatic failure: the scenario in Bangladesh and the differences from the west.

Authors:  Shahinul Alam; Golam Azam; Golam Mustafa; Abul Kalam Azad; Izazul Haque; Shakil Gani; Nooruddin Ahmad; Khorshed Alam; Mobin Khan
Journal:  Saudi J Gastroenterol       Date:  2009 Oct-Dec       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.